Clean Earth Acquisitions Valuation
Is CLIN.U undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CLIN.U when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CLIN.U ($4.8) is trading below our estimate of fair value ($51.52)
Significantly Below Fair Value: CLIN.U is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CLIN.U?
Key metric: As CLIN.U is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is CLIN.U's PE Ratio? | |
|---|---|
| PE Ratio | 20.1x |
| Earnings | US$4.16m |
| Market Cap | US$83.52m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does CLIN.U's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 67.3x | ||
BLEU bleuacacia | 124.5x | n/a | US$83.3m |
AITR AI Transportation Acquisition | 49.3x | n/a | US$83.1m |
EAC Edify Acquisition | 78.5x | n/a | US$84.0m |
FICV Frontier Investment | 16.8x | n/a | US$82.8m |
CLIN.U Clean Earth Acquisitions | 20.1x | n/a | US$83.5m |
Price-To-Earnings vs Peers: CLIN.U is good value based on its Price-To-Earnings Ratio (20.1x) compared to the peer average (43.2x).
Price to Earnings Ratio vs Industry
How does CLIN.U's PE Ratio compare vs other companies in the US Capital Markets Industry?
| 23 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
ADX Adams Diversified Equity Fund | 3.6x | n/a | US$2.28b |
CET Central Securities | 4.5x | n/a | US$1.32b |
GAM General American Investors Company | 4.1x | n/a | US$1.17b |
MUDS Mudrick Capital Acquisition Corporation II | 3.4x | n/a | US$401.64m |
| 23 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: CLIN.U is good value based on its Price-To-Earnings Ratio (20.1x) compared to the US Capital Markets industry average (27.9x).
Price to Earnings Ratio vs Fair Ratio
What is CLIN.U's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 20.1x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CLIN.U's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Guild Holdings
US$844.7m
Guild Holdings Company originates, sells, and services residential mortgage loans in the United States.
GHLD
US$13.65
7D
-2.4%
1Y
7.2%
FinVolution Group
US$1.6b
Operates in the online consumer finance industry.
FINV
US$6.18
7D
4.0%
1Y
34.6%
Federal Home Loan Mortgage
US$10.0b
Operates in the secondary mortgage market in the United States.
FMCC
US$3.10
7D
3.3%
1Y
384.4%